PharmaTRACC News 4/27
04/27/2011
Our client is interested in acquiring U.S. marketed generic and branded generic pharmaceutical products. The focus is more opportunistic and less therapeutic category specific, however, derm products would have a slightly higher priority.
Primary interest is in products generating $15mm or less in annual sales.